je.st
news
Approval of breast cancer treatment triggers $5M payment to Immunogen
2013-09-20 21:16:15| Biotech - Topix.net
Immunogen Inc., led by CEO Daniel Junius, has received a $5M milestone payment for its role in Kadcyla receiving approval in Japan.
Tags: to
treatment
payment
approval
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||